|
| 36734148 | Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. | | 2023 |
| 36897180 | Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. | | 2023 |
| 36481383 | Sexual dysfunction in female patients with anal cancer treated with curative intent: A systematic review of the literature. | | 2023 |
| 34694948 | Use of a vaginal CO laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review. | Climacteric | 2022 |
| 35526662 | First reported case of Robinsoniella peoriensis pyometra and bloodstream infection: A case report and review of the literature. | Anaerobe | 2022 |
| 35577425 | Directive clinique n 422g : Ménopause et ostéoporose. | Journal of Obstetrics and Gynaecology Canada | 2022 |
| 35577424 | Guideline No. 422g: Menopause and Osteoporosis. | Journal of Obstetrics and Gynaecology Canada | 2022 |
| 35213521 | Comparing estrogen-based hormonal contraceptives and hormone therapy on bone mineral density in women with premature ovarian insufficiency: a systematic review. | Menopause | 2022 |
| 35181013 | Corrigendum to 'Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle' [J Obstet Gynaecol Can 43 (2021) 1188-1204]. | Journal of Obstetrics and Gynaecology Canada | 2022 |
| 34537418 | Guideline No. 422d: Menopause and Sexuality. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 33906204 | A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. | Menopause | 2021 |
| 33759668 | The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review. | Climacteric | 2021 |
| 33973541 | A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative. | Menopause | 2021 |
| 34506989 | Guideline No. 422b: Menopause and Genitourinary Health. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34390867 | Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34555546 | Directive clinique n 422d : Ménopause et sexualité. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34555545 | Directive clinique n 422b : Ménopause et santé génito-urinaire. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34555544 | Directive clinique n° 422c : Ménopause : Humeur, sommeil et cognition. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34895584 | Directive clinique n 422f : Ménopause et cancer du sein. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34895583 | Guideline No. 422f: Menopause and Breast Cancer. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34895582 | Directive clinique n 422e : Ménopause et maladies cardiovasculaires. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34895581 | Guideline No. 422e: Menopause and Cardiovascular Disease. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34758906 | Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 34649685 | Directive clinique n 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie. | Journal of Obstetrics and Gynaecology Canada | 2021 |
| 31241369 | Medical and gynecological comorbidities in adult women with Turner syndrome: our multidisciplinary clinic experience. | Climacteric | 2020 |
| 31687921 | O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. | Radiology | 2020 |
| 32796289 | Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers. | Menopause | 2020 |
| 32736856 | | Journal of Obstetrics and Gynaecology Canada | 2020 |
| 32736855 | Guideline No. 404: Initial Investigation and Management of Benign Ovarian Masses. | Journal of Obstetrics and Gynaecology Canada | 2020 |
| 32898023 | Unnecessary bilateral salpingo-oophorectomy at the time of hysterectomy and potential for ovarian preservation. | Menopause | 2020 |
| 32896176 | Premature ovarian insufficiency: an International Menopause Society White Paper. | Climacteric | 2020 |
| 30879488 | N 377- Indications gynécologiques bénignes de l'hystérectomie. | Journal of Obstetrics and Gynaecology Canada | 2019 |
| 31315476 | Vulvovaginal graft-versus-host disease: a review. | Climacteric | 2019 |
| 31151565 | N° 311 - Prise en charge de la ménopause (Résumé/Déclarations Sommaires et Recommandations). | Journal of Obstetrics and Gynaecology Canada | 2019 |
| 30879487 | No. 377-Hysterectomy for Benign Gynaecologic Indications. | Journal of Obstetrics and Gynaecology Canada | 2019 |
| 29731210 | No. 249-Asymptomatic Endometrial Thickening. | Journal of Obstetrics and Gynaecology Canada | 2018 |
| 30025870 | Survey of Canadian PGY-4 and PGY-5 Obstetrics and Gynaecology Residents on Knowledge of and Exposure to Premature Ovarian Insufficiency. | Journal of Obstetrics and Gynaecology Canada | 2018 |
| 29987939 | Sexual well-being after menopause: An International Menopause Society White Paper. | Climacteric | 2018 |
| 29731218 | N 292-Saignements utérins anormaux chez les femmes préménopausées. | Journal of Obstetrics and Gynaecology Canada | 2018 |
| 29731212 | No. 292-Abnormal Uterine Bleeding in Pre-Menopausal Women. | Journal of Obstetrics and Gynaecology Canada | 2018 |
| 29731211 | N 249-ÿpaississement endométrial asymptomatique. | Journal of Obstetrics and Gynaecology Canada | 2018 |
| 28266033 | First International Consensus Report on Adnexal Masses: Management Recommendations. | Journal of Ultrasound in Medicine | 2017 |
| 28680280 | Interventions to address sexual problems in people with cancer. | | 2017 |
| 28609392 | The role of hormone therapy in the management of severe postpartum depression in patients with Turner syndrome. | Menopause | 2017 |
| 29080729 | Letter to the Editor. | Journal of Obstetrics and Gynaecology Canada | 2017 |
| 28063539 | Saignements utérins anormaux chez les femmes préménopausées. | Journal of Obstetrics and Gynaecology Canada | 2016 |
| 27679215 | The Role of Ethnicity in the Treatment of Uterine Fibroids With Ulipristal Acetate. | Journal of Minimally Invasive Gynecology | 2015 |
| 26001691 | Endometrial ablation in the management of abnormal uterine bleeding. | Journal of Obstetrics and Gynaecology Canada | 2015 |
| 25222364 | Managing menopause. | Journal of Obstetrics and Gynaecology Canada | 2014 |
| 23485948 | Endometrial thickness in 1,500 asymptomatic postmenopausal women not on hormone replacement therapy. | Gynecologic and Obstetric Investigation | 2013 |